Over-labelled Medicines Framework
key details
| Status | planned |
|---|---|
| Category (CPV) | 33600000 |
| Contract start | 15 Jun 2026 |
| Contract end | 16 Jun 2028 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-4f2417a7-2414-43fd-ad13-e62c663da2b9 |
description
NHS LPP is considering setting up a framework agreement or Dynamic Market for over-labelled medicines used in clinical and out-of-hours settings. Over-labelled medicines are typically used in settings like hospitals, prisons, community health services or prisons where pre-labelled packs improve efficiency and patient safety. Progression and the final structure and scope of the agreement are subject to change following a market needs assessment.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 23 May 2025 | Planning (planning) | · | 3ec07c3d-1f6d-4ab6-94dc-1caa63d8dee0-846772 |
more from NHS London Procurement Partnership
- Liquid Nitrogen · 23 May 2025
- Telemedicine and Virtual Ward Services · 23 May 2025
- Integrated Dental Care · 23 May 2025
- Wholesale Pharmaceutical Framework · 23 May 2025
- Total Facilities Management · 21 May 2025
- G-Cloud 12 Pi Ltd - NHS LPP 2022 · £798,788 · 22 Sept 2022
- Mini Competition for the Provision of Lift Maintenance Services · 25 Apr 2022
- Estates & Facilities Consultancy Dynamic Purchasing System · 23 Feb 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.